PegBio Co Ltd Sustainability Reports
PegBio Co., Ltd. is a clinical-stage biopharmaceutical company focused on the discovery, research, and development of innovative therapies for chronic and metabolic disorders, primarily long-acting peptide drugs targeting diabetes and obesity.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01V3WS5S4
1 reports from 2025 to 2025
